MAOB and Parkinson disease: Previous studies reported changes in plasma levels of noradrenaline and adrenaline in patients with PD who used MAO-B inhibitors (Stryjer et al., 2005; Pursiainen et al., 2007), which regulate BP (Ricci et al., 2015; Umehara et al., 2018).